Sintx Technologies Dividenden en inkoop

Dividend criteriumcontroles 0/6

Sintx Technologies heeft geen dividenduitkeringen gedaan.

Belangrijke informatie

n/a

Dividendrendement

-76.0%

Terugkoop Rendement

Totaal aandeelhoudersrendement	-76.0%
Toekomstig dividendrendement	n/a
Dividendgroei	n/a
Volgende betaaldatum dividend	n/a
Ex-dividenddatum	n/a
Dividend per aandeel	n/a
Uitbetalingsratio	n/a

Recente updates van dividend en inkoop

Geen updates

Recent updates

Nieuw narratief • Sep 09

Silicon Nitride Biomaterials And Industrial Orders Will Drive A Turnaround Story

Catalysts About Sintx Technologies Sintx Technologies develops and manufactures advanced silicon nitride based biomaterials and high performance ceramic components for medical and industrial customers. What are the underlying business or industry changes driving this perspective?

Nieuw narratief • Aug 26

Silicon Nitride Platform And Contract Manufacturing Orders Will Drive Long-Term Medical Market Upside

Catalysts About Sintx Technologies Sintx Technologies is a biomaterials and medical technology company focused on silicon nitride based components for industrial and medical applications. What are the underlying business or industry changes driving this perspective?

Nieuw narratief • Aug 12

High Risk Ceramics Expansion Will Test Outsourced Manufacturing Before Potential Upside Emerges

Catalysts About Sintx Technologies Sintx Technologies develops and manufactures advanced silicon nitride based biomaterials and technical ceramics for medical and industrial customers. What are the underlying business or industry changes driving this perspective?

Analyse-artikel • Nov 29

It's Unlikely That The CEO Of Sintx Technologies, Inc. (NASDAQ:SINT) Will See A Huge Pay Rise This Year

Key Insights Sintx Technologies' Annual General Meeting to take place on 5th of December CEO B. Bal's total...

Analyse-artikel • Dec 09

Most Shareholders Will Probably Find That The Compensation For Sintx Technologies, Inc.'s (NASDAQ:SINT) CEO Is Reasonable

Performance at Sintx Technologies, Inc. ( NASDAQ:SINT ) has been rather uninspiring recently and shareholders may be...

Seeking Alpha • Oct 11

SINTX Technologies jumps 25%, gets order for aerospace components

SINTX Technologies (NASDAQ:SINT) has received a production order for silicon nitride components in a critical commercial jet application from a global aerospace manufacturer. The receipt of the order follows a lengthy qualification period which included assessment of company’s operational and quality management systems as well as evaluation of prototypes. Don Bray, VP of Business Development for SINTX commented, “Our silicon nitride manufacturing process is certified to the rigorous AS9100D standard which is a requirement for this application and allowed SINTX to compete for this order. We have several other aerospace and industrial components in evaluation now and expect additional orders in the near future. We believe that our materials technology is very strong, and this aerospace segment is a growth area for SINTX.” Stock rises 25% during pre-market.

Seeking Alpha • Sep 27

SINTX Technologies stock gains 8% premarket on $1.1M grant awarded by US Dept of Energy

SINTX Technologies (NASDAQ:SINT) stock gained 8.1% premarket on Tuesday after the firm announced a phase II award of $1.1M from the U.S. Dept. of Energy. The grant is for development and design of 3D-printed alumina ceramic heat exchangers for heating, ventilation and air conditioning systems (HVAC). The proposal was originally submitted by Technology Assessment and Transfer, which is now a unit of SINT.

Seeking Alpha • Jul 06

SINTX Technologies acquires Technology Assessment and Transfer

Original equipment manufacturer of advanced ceramics, SINTX Technologies (NASDAQ:SINT) acquires Technology Assessment and Transfer, significantly increasing company’s capabilities in the aerospace, defense, and biomedical markets. TA&T, based in Maryland, is a nearly 40-year-old advanced ceramics business that specializes in developing and commercializing a broad array of innovative materials for defense, biomedical, and industrial applications. “We are excited to acquire TA&T and take another step towards diversifying and strengthening SINTX. TA&T will expand our use of advanced manufacturing technologies and introduce new ceramic material platforms to the SINTX portfolio. We expect the acquisition to bring immediate revenue to SINTX via TA&T’s well-established relationships with commercial partners and the U.S. government.” said Dr. Sonny Bal, President and CEO.

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: Er zijn onvoldoende gegevens om te bepalen of het dividend per aandeel van SINT in het verleden stabiel is geweest.

Groeiend dividend: Er zijn onvoldoende gegevens om te bepalen of de dividendbetalingen van SINT zijn gestegen.

Dividendrendement versus markt

Sintx Technologies Dividendrendement versus markt

Hoe verhoudt SINT dividendrendement zich tot de markt?
Segment	Dividendrendement
Bedrijf (SINT)	n/a
Markt onderkant 25% (US)	1.4%
Markt Top 25% (US)	4.1%
Gemiddelde industrie (Medical Equipment)	2.0%
Analist prognose (SINT) (tot 3 jaar)	n/a

Opmerkelijk dividend: Het dividendrendement van SINT kan niet worden vergeleken met dat van de onderste 25% van de dividendbetalers, aangezien het bedrijf geen recente uitbetalingen heeft gerapporteerd.

Hoog dividend: Het dividendrendement van SINT kan niet worden vergeleken met dat van de top 25% van de dividendbetalers, aangezien het bedrijf geen recente uitbetalingen heeft gerapporteerd.

Winstuitkering aan aandeelhouders

Verdiendekking: Er zijn onvoldoende gegevens om de payout ratio SINT te berekenen en vast te stellen of de dividendbetalingen worden gedekt door de winst.

Contante uitbetaling aan aandeelhouders

Kasstroomdekking: De duurzaamheid van het dividend kan niet worden berekend, omdat SINT geen uitbetalingen heeft gerapporteerd.

Ontdek bedrijven met een sterk dividend

Bedrijfsanalyse en status van financiële gegevens

Gegevens	Laatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse	2026/09/12 19:01
Aandelenkoers aan het einde van de dag	2026/09/11 00:00
Inkomsten	2026/06/30
Jaarlijkse inkomsten	2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

Pakket	Gegevens	Tijdframe	Voorbeeld Amerikaanse bron ^*
Financiële gegevens bedrijf	10 jaar	Resultatenrekening Kasstroomoverzicht Balans	SEC-formulier 10-K SEC-formulier 10-Q
Consensus schattingen analisten	+3 jaar	Financiële prognoses Koersdoelen analisten	Onderzoeksrapporten van analisten Blue Matrix
Marktprijzen	30 jaar	Aandelenprijzen Dividenden, splitsingen en acties	ICE Marktgegevens SEC-formulier S-1
Eigendom	10 jaar	Top aandeelhouders Handel met voorkennis	SEC-formulier 4 SEC-formulier 13D
Beheer	10 jaar	Leiderschapsteam Raad van bestuur	SEC-formulier 10-K SEC-formulier DEF 14A
Belangrijkste ontwikkelingen	10 jaar	Bedrijfsaankondigingen	SEC-formulier 8-K

^* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Sintx Technologies, Inc. wordt gevolgd door 7 analisten. 3 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

Analist	Instelling
Edward Woo	Ascendiant Capital Markets LLC
David Turkaly	Citizens JMP Securities, LLC
Brandon Folkes	H.C. Wainwright & Co.

Sintx Technologies Dividenden en inkoop

Dividend criteriumcontroles 0/6

Belangrijke informatie

Recente updates van dividend en inkoop

Recent updates

Silicon Nitride Biomaterials And Industrial Orders Will Drive A Turnaround Story

Silicon Nitride Platform And Contract Manufacturing Orders Will Drive Long-Term Medical Market Upside

Second quarter 2026 earnings: EPS and revenues miss analyst expectations

SINTX Technologies, Inc. Provides Revenue Guidance for the Third and Fourth Quarters of 2026

High Risk Ceramics Expansion Will Test Outsourced Manufacturing Before Potential Upside Emerges

Sintx Technologies, Inc. to Report Q2, 2026 Results on Aug 11, 2026

New major risk - Financial position

Sintx Technologies, Inc. announced that it has received $4.5 million in funding

Sintx Technologies, Inc. Receives Nasdaq Notice Of Non-Compliance With Listing Rule 5550(b)(1)

Consensus revenue estimates increase by 46%, EPS downgraded

New major risk - Financial position

First quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus revenue estimates fall by 29%

Full year 2025 earnings: EPS and revenues miss analyst expectations

New major risk - Revenue and earnings growth

New major risk - Market cap size

Sintx Technologies, Inc. Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC Foot & Ankle Implant

Sintx Technologies, Inc. Announces Cessation of Eric Olson as President, Effective March 16, 2026

Sintx Technologies, Inc. Appoints Ryan Elmore as President, Effective March 16, 2026

Consensus EPS estimates fall by 111%

Chief Investment Officer & Director recently bought US$255k worth of stock

Third quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

SINTX Technologies, Inc. Announces Launch of OsseoSculpt an Advanced Biologic for Use with SINAPTIC Foot & Ankle Osteotomy Wedge System

SINTX Technologies, Inc. Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fibrous Materials

Sintx Technologies, Inc. has filed a Follow-on Equity Offering in the amount of $6.413876 million.

Price target decreased by 11% to US$25.00

Consensus revenue estimates decrease by 38%, EPS upgraded

SINTX Technologies, Inc. Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

New minor risk - Share price stability

Sintx Technologies, Inc. Publishes Study Demonstrating Broad-Spectrum Antiviral Activity of Silicon Nitride

Chief Investment Officer & Director recently bought US$185k worth of stock

Second quarter 2025 earnings: EPS and revenues miss analyst expectations

SINTX Technologies, Inc. Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

SINTX Technologies, Inc. Submits FDA 510(k) for Silicon Nitride Foot & Ankle Medical Devices

Sintx Technologies, Inc. Announces Executive Appointments

Consensus revenue estimates fall by 45%

First quarter 2025 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Sintx Technologies, Inc. Announces Board Changes

Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Sintx Technologies Announces Board Chairman Changes

Sintx Technologies, Inc. announced that it has received $5.000012 million in funding

Tethon Corporation acquired Technology Assessment & Transfer, Inc. from Sintx Technologies, Inc. (NasdaqCM:SINT).

Sintx Technologies, Inc. Appoints Eric K. Olson to the Board of Directors

Insufficient new directors

Sintx Technologies, Inc.Appoints Gregg R. Honigblum as Chief Strategy Officer

Sintx Technologies, Inc., Annual General Meeting, Dec 19, 2024

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates upgraded to US$16.25 loss

Sintx Technologies, Inc. Announces Key Executive Promotions: Ryan Bock, Phd, Named Chief Technology Officer and Ann Kutsch Promoted to President of Sintx Ta&T

Sintx Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $3.114779 million.

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Sintx Technologies, Inc. Announces Appointment of Eric K. Olson as Chief Executive Officer

Sintx Technologies, Inc. has filed a Follow-on Equity Offering in the amount of $3.115475 million.

Consensus EPS estimates fall by 594%

Sintx Technologies Regains Compliance with Nasdaq Bid Price Requirement

Consensus revenue estimates decrease by 12%

Sintx Technologies Declares 1-for-200 Reverse Stock Split Effective May 28, 2024 to Bring it into Compliance with the Minimum Bid Price Requirements for Maintaining the Listing on the Nasdaq Capital Market

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Sintx Technologies Receives New Notification Letter from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement for Continued Listing on The Nasdaq Capital Market

Sintx Technologies, Inc. has filed a Follow-on Equity Offering.

Full year 2023 earnings: EPS misses analyst expectations

Sintx Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $1.030519 million.

Consensus revenue estimates increase by 17%

Sintx Technologies, Inc. Provides Estimated Revenue for the Fourth Quarter and Full Year Ended December 31, 2023

It's Unlikely That The CEO Of Sintx Technologies, Inc. (NASDAQ:SINT) Will See A Huge Pay Rise This Year

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Sintx Technologies, Inc., Annual General Meeting, Dec 05, 2023

SINTX Technologies Receives a Notice from Nasdaq Listing Qualifications Department of the Nasdaq Stock Market

Sintx Technologies, Inc. Receives Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

New major risk - Revenue and earnings growth

No longer forecast to breakeven

Second quarter 2023 earnings released: US$0.61 loss per share (vs US$10.16 loss in 2Q 2022)

Consensus EPS estimates fall by 16%

Consensus EPS estimates upgraded to US$2.53 loss